Universe Pharmaceuticals (UPC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.93, -5.30% vs the prior close of $4.15.
- Volume 7.72K shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
UPC slides 5.3% to $3.93, a 1-month low, 3 down days in a row. Closed at $3.93, -5.30% vs the prior close of $4.15. Day range $3.93–$4.10, opened at $4.10.
UPC daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — UPC slides 5.3% to $3.93, a 1-month low, 3 down days in a row
- Closed at $3.93, -5.30% vs the prior close of $4.15. Day range $3.93–$4.10, opened at $4.10.
- Volume was 7.72K shares, 0.0x its 50-day average of 162.92K — lighter than usual.
- Price is -17.7% vs its 50-day average ($4.77) and +1.4% vs its 200-day average ($3.87).
- 52-week range $2.00–$17.96; today's close sits at 12% of that range, 78.1% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 — UPC ends flat (+0.0%) to $4.15
- Closed at $4.15, +0.00% vs the prior close of $4.15. Day range $4.00–$4.28, opened at $4.03.
- Volume was 4.60K shares, 0.0x its 50-day average of 168.40K — lighter than usual.
- Price is -13.9% vs its 50-day average ($4.82) and +7.1% vs its 200-day average ($3.87).
- 52-week range $2.00–$17.96; today's close sits at 13% of that range, 76.9% below the 52-week high.
Oct 14, 2026 — UPC dips 2.8% to $4.15
- Closed at $4.15, -2.81% vs the prior close of $4.27. Day range $4.14–$4.27, opened at $4.17.
- Volume was 4.00K shares, 0.0x its 50-day average of 183.52K — lighter than usual.
- Price is -14.6% vs its 50-day average ($4.86) and +7.1% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 13% of that range, 76.9% below the 52-week high.
Oct 13, 2026 — UPC jumps 3.4% to $4.27
- Closed at $4.27, +3.39% vs the prior close of $4.13. Day range $4.09–$4.40, opened at $4.25.
- Volume was 8.30K shares, 0.0x its 50-day average of 743.97K — lighter than usual.
- Price is -13.2% vs its 50-day average ($4.92) and +10.0% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 14% of that range, 76.2% below the 52-week high.
Oct 12, 2026 — UPC dips 0.5% to $4.13, a 1-month low, 3 down days in a row
- Closed at $4.13, -0.48% vs the prior close of $4.15. Day range $4.07–$4.30, opened at $4.09.
- Volume was 18.50K shares, 0.0x its 50-day average of 980.25K — lighter than usual.
- Price is -16.8% vs its 50-day average ($4.96) and +6.4% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 13% of that range, 77.0% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — UPC dips 0.7% to $4.15
- Closed at $4.15, -0.72% vs the prior close of $4.18. Day range $3.96–$4.21, opened at $4.05.
- Volume was 12.10K shares, 0.0x its 50-day average of 980.40K — lighter than usual.
- Price is -16.0% vs its 50-day average ($4.94) and +6.9% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 13% of that range, 76.9% below the 52-week high.
Oct 8, 2026 — UPC dips 2.9% to $4.18
- Closed at $4.18, -2.90% vs the prior close of $4.30. Day range $4.03–$4.42, opened at $4.42.
- Volume was 12.60K shares, 0.0x its 50-day average of 981.55K — lighter than usual.
- Price is -15.2% vs its 50-day average ($4.93) and +7.8% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 14% of that range, 76.7% below the 52-week high.
Oct 7, 2026 — UPC rises 2.3% to $4.30
- Closed at $4.30, +2.26% vs the prior close of $4.21. Day range $4.18–$4.48, opened at $4.33.
- Volume was 32.80K shares, 0.0x its 50-day average of 981.65K — lighter than usual.
- Price is -12.3% vs its 50-day average ($4.91) and +11.0% vs its 200-day average ($3.88).
- 52-week range $2.00–$17.96; today's close sits at 14% of that range, 76.0% below the 52-week high.
Oct 6, 2026 — UPC dips 3.0% to $4.21
- Closed at $4.21, -3.00% vs the prior close of $4.34. Day range $4.20–$4.64, opened at $4.35.
- Volume was 26.00K shares, 0.0x its 50-day average of 981.72K — lighter than usual.
- Price is -13.9% vs its 50-day average ($4.89) and +8.7% vs its 200-day average ($3.87).
- 52-week range $2.00–$17.96; today's close sits at 14% of that range, 76.6% below the 52-week high.
- SEC filings that day: 6-K.
Oct 5, 2026 — UPC slides 3.6% to $4.34
- Closed at $4.34, -3.56% vs the prior close of $4.50. Day range $4.34–$4.64, opened at $4.48.
- Volume was 7.90K shares, 0.0x its 50-day average of 982.43K — lighter than usual.
- Price is -11.0% vs its 50-day average ($4.87) and +12.1% vs its 200-day average ($3.87).
- 52-week range $2.00–$17.96; today's close sits at 15% of that range, 75.8% below the 52-week high.
Oct 2, 2026 — UPC jumps 4.4% to $4.50
- Closed at $4.50, +4.41% vs the prior close of $4.31. Day range $4.34–$4.63, opened at $4.41.
- Volume was 107.00K shares, 0.1x its 50-day average of 981.27K — lighter than usual.
- Price is -7.3% vs its 50-day average ($4.85) and +16.4% vs its 200-day average ($3.87).
- 52-week range $2.00–$17.96; today's close sits at 16% of that range, 74.9% below the 52-week high.
UPC latest news & SEC filings
Every SEC filing by or about UPC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form F-3 — F-3 filing
F-3 filing
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 29, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade UPC
- How much it moves: over the last 20 sessions the average daily move was 2.41% (largest 5.8%).
- Liquidity: about 38.91K shares (≈$152.92K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.93 vs a range of $2.00–$17.96 (12% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:40 on Mar 24, 2025, 1:15 on Nov 18, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Oct 6, 2026; 6-K Sep 1, 2026; 6-K Jul 31, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
UPC market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.10 | 4.10 | 3.93 | 3.93 | 7.72K |
| Oct 15, 2026 | 4.03 | 4.28 | 4.00 | 4.15 | 4.60K |
| Oct 14, 2026 | 4.17 | 4.27 | 4.14 | 4.15 | 4.00K |
| Oct 13, 2026 | 4.25 | 4.40 | 4.09 | 4.27 | 8.30K |
| Oct 12, 2026 | 4.09 | 4.30 | 4.07 | 4.13 | 18.50K |
| Oct 9, 2026 | 4.05 | 4.21 | 3.96 | 4.15 | 12.10K |
| Oct 8, 2026 | 4.42 | 4.42 | 4.03 | 4.18 | 12.60K |
| Oct 7, 2026 | 4.33 | 4.48 | 4.18 | 4.30 | 32.80K |
| Oct 6, 2026 | 4.35 | 4.64 | 4.20 | 4.21 | 26.00K |
| Oct 5, 2026 | 4.48 | 4.64 | 4.34 | 4.34 | 7.90K |
| Oct 2, 2026 | 4.41 | 4.63 | 4.34 | 4.50 | 107.00K |
| Oct 1, 2026 | 4.36 | 4.69 | 4.21 | 4.31 | 228.80K |
| Sep 30, 2026 | 4.51 | 4.74 | 4.25 | 4.30 | 131.50K |
| Sep 29, 2026 | 4.68 | 4.81 | 4.51 | 4.52 | 13.70K |
| Sep 28, 2026 | 4.70 | 4.99 | 4.61 | 4.80 | 28.20K |
| Sep 25, 2026 | 4.81 | 4.88 | 4.64 | 4.75 | 23.50K |
| Sep 24, 2026 | 4.72 | 4.80 | 4.61 | 4.68 | 33.30K |
| Sep 23, 2026 | 4.56 | 4.83 | 4.50 | 4.69 | 20.20K |
| Sep 22, 2026 | 4.60 | 4.83 | 4.56 | 4.66 | 13.50K |
| Sep 21, 2026 | 4.86 | 5.04 | 4.51 | 4.64 | 44.00K |
About Universe Pharmaceuticals
Universe Pharmaceuticals (UPC) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in JI'AN, JIANGXI, China. State of incorporation: China. Fiscal year ends September 30. SEC CIK 1809616.
UPC board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gang Lai | Chief Executive Officer | May 21, 2026 |
| Jiawen Pang | Director | Mar 18, 2026 |
| Lin (Lydia) Yang | Chief Financial Officer | Mar 18, 2026 |
| Yongping Yu | Director | Mar 18, 2026 |
| Ding Zheng | Director | Mar 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gang Lai | Chief Executive Officer | May 21, 2026 |
| Baochang Liu | Chief Operating Officer | Mar 18, 2026 |
| Lin (Lydia) Yang | Chief Financial Officer | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
UPC financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
UPC earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on UPC
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.